Is aflatoxin B1 bioactivated in the liver to a reactive epoxide that causes oxidative hepatocellular injury?

Aflatoxin B1 (AFB1), a potent mycotoxin produced by Aspergillus species, is a well-established hepatocarcinogen and hepatotoxin. The pathobiology of AFB1-induced liver damage centers on its metabolic transformation and subsequent oxidative cascade within hepatocytes.

Clinical and effectiveness evidence

• Primary hepatocyte toxicity: In human hepatic models, exposure to AFB1 results in dose-dependent cytotoxicity and cell death.
• Human biomarker association: Studies in exposed human cohorts reveal a direct correlation between the levels of bioactivated AFB1-DNA adducts (such as AFB1-N7-guanine) in urine or tissue and clinical markers of acute hepatic injury and chronic hepatocellular carcinoma risk.
• Antioxidant mitigation: Clinical and preclinical trials evaluating protective agents, such as green tea polyphenols or chlorophyllin, demonstrate that enhancing phase II conjugation or reducing phase I activation significantly lowers biomarker levels of oxidative damage and protects liver function.

Mechanistic explanations

• Cytochrome P450 bioactivation: AFB1 is a pro-carcinogen that requires metabolic activation. In the liver, Cytochrome P450 enzymes—predominantly CYP1A2 (high-affinity, low-capacity) and CYP3A4 (high-capacity)—catalyze the oxidation of the 8,9-double bond of AFB1 to form the highly reactive, electrophilic exo-aflatoxin B1-8,9-epoxide (AFBO).
• ROS generation and mitochondrial dysfunction: AFBO accumulation triggers a dramatic increase in intracellular reactive oxygen species (ROS), including superoxide and hydrogen peroxide. This is driven by both microsomal P450 catalytic activity and AFBO-induced disruption of the mitochondrial electron transport chain, which depolarizes the mitochondrial membrane.
• Depletion of antioxidant defenses: AFBO rapidly depletes cellular glutathione (GSH) reserves through both spontaneous reaction and glutathione S-transferase (GST)-mediated conjugation. This depletion downregulates key endogenous antioxidant enzymes, including superoxide dismutase (SOD) and glutathione peroxidase 4 (GPX4).
• Lipid peroxidation and cell death: The resulting unchecked oxidative stress initiates extensive lipid peroxidation of hepatocellular membranes (marked by significant elevations in malondialdehyde). This oxidative cascade, paired with genomic DNA adduct formation, ultimately drives hepatocytes toward apoptotic and ferroptotic cell death pathways.

Bottom line

Aflatoxin B1 is bioactivated in the liver by CYP1A2 and CYP3A4 into the highly reactive exo-AFB1-8,9-epoxide, which directly drives severe oxidative hepatocellular injury through mitochondrial impairment, glutathione depletion, and lipid peroxidation.